Clinical Trial Data on Post-Abortion Recovery with Three Medication Regimens

A single-center randomized controlled trial in China evaluated 380 patients after artificial abortion. The dataset contains outcomes for three treatment groups comparing Honghua Ruyi Pills, estradiol valerate plus dydrogesterone, and their combination. Results from the 21-day treatment period were published by Bing Zhou in 2026.

Use Cases

• Compare treatment efficacy for endometrial thickness based on the primary outcome measure.
• Analyze time to postoperative symptom resolution based on secondary outcomes like abdominal pain and bleeding duration.
• Model the relationship between medication combinations and menstrual recovery metrics like resumption time and volume.
• Assess adverse reaction profiles across different drug regimens mentioned in the trial results.

Strengths

• Data originates from a randomized, double-blind, double-dummy controlled trial with 380 participants.
• Includes multiple clinical endpoints such as endometrial thickness, pain duration, bleeding duration, and menstrual metrics.
• Results show statistically significant differences (p-values reported) between the combination therapy and single treatments.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The trial is single-center, and the authors note findings are hypothesis-generating and require multicenter confirmation.

Provenance

Source

figshare, author Bing Zhou.

Collection Method

Randomized, double-blind, double-dummy, controlled clinical trial.

Time Range

Trial outcomes assessed over a 21-day treatment period.

Freshness

Last updated 2026-04-22 05:46:06; freshness should be verified.

Geography

Conducted at a single center, likely in China based on the medication names.